Cited 0 time in
Target movement according to cervical lymph node level in head and neck cancer and its clinical significance
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Hoon Sik | - |
| dc.contributor.author | Jeong, Bae Kwon | - |
| dc.contributor.author | Jeong, Hojin | - |
| dc.contributor.author | Ha, In Bong | - |
| dc.contributor.author | Choi, Bong-Hoi | - |
| dc.contributor.author | Kang, Ki Mun | - |
| dc.date.accessioned | 2024-03-24T02:30:46Z | - |
| dc.date.available | 2024-03-24T02:30:46Z | - |
| dc.date.issued | 2023-12 | - |
| dc.identifier.issn | 2234-1900 | - |
| dc.identifier.issn | 2234-3156 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/70017 | - |
| dc.description.abstract | Purpose: To evaluate set-up error for head and neck cancer (HNC) patients according to each neck lymph node (LN) level. And clinical factors affecting set-up error were analyzed. Materials and Methods: Reference points (RP1, RP2, RP3, and RP4) representing neck LN levels I to IV were designated. These RP were contoured on simulation computed tomography (CT) and conebeam CT of 89 HNC patients with the same standard. After image registration was performed, movement of each RP was measured. Univariable logistic regression analyses were performed to analyze clinical factors related to measured movements. Results: The mean value of deviation of all axes was 1.6 mm, 1.3 mm, 1.8 mm, and 1.5 mm for RP1, RP2, RP3, and RP4, respectively. Deviation was over 3 mm in 24 patients. Movement of more than 3 mm was observed only in RP1 and RP3. In RP1, it was related to bite block use. Movement exceeding 3 mm was most frequently observed in RP3. Primary tumor and metastatic LN volume change were clinical factors related to the RP3 movement. Conclusion: Planning target volume margin of 4 mm for neck LN level I, 3 mm for neck LN level II, 5 mm for neck LN level III, and 3 mm for neck LN level IV was required to include all movements of each LN level. In patients using bite block, changes in primary tumor volume, and metastatic LN volume were related to significant movement. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society for Therapeutic Radiology and Oncology | - |
| dc.title | Target movement according to cervical lymph node level in head and neck cancer and its clinical significance | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3857/roj.2023.00787to | - |
| dc.identifier.scopusid | 2-s2.0-85181882317 | - |
| dc.identifier.wosid | 001167401300008 | - |
| dc.identifier.bibliographicCitation | Radiation Oncology Journal, v.41, no.4, pp 283 - 291 | - |
| dc.citation.title | Radiation Oncology Journal | - |
| dc.citation.volume | 41 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 283 | - |
| dc.citation.endPage | 291 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART003029391 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | SET-UP ERRORS | - |
| dc.subject.keywordPlus | IMRT | - |
| dc.subject.keywordPlus | RADIOTHERAPY | - |
| dc.subject.keywordPlus | CBCT | - |
| dc.subject.keywordAuthor | Head and neck neoplasms | - |
| dc.subject.keywordAuthor | Planning target volume | - |
| dc.subject.keywordAuthor | Neck lymph nodes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
